» Articles » PMID: 17353275

Differential Regulation of Foxo3a Target Genes in Erythropoiesis

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2007 Mar 14
PMID 17353275
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The cooperation of stem cell factor (SCF) and erythropoietin (Epo) is required to induce renewal divisions in erythroid progenitors, whereas differentiation to mature erythrocytes requires the presence of Epo only. Epo and SCF activate common signaling pathways such as the activation of protein kinase B (PKB) and the subsequent phosphorylation and inactivation of Foxo3a. In contrast, only Epo activates Stat5. Both Foxo3a and Stat5 promote erythroid differentiation. To understand the interplay of SCF and Epo in maintaining the balance between renewal and differentiation during erythroid development, we investigated differential Foxo3a target regulation by Epo and SCF. Expression profiling revealed that a subset of Foxo3a targets was not inhibited but was activated by Epo. One of these genes was Cited2. Transcriptional control of Epo/Foxo3a-induced Cited2 was studied and compared with that of the Epo-repressed Foxo3a target Btg1. We show that in response to Epo, the allegedly growth-inhibitory factor Foxo3a associates with the allegedly growth-stimulatory factor Stat5 in the nucleus, which is required for Epo-induced Cited2 expression. In contrast, Btg1 expression is controlled by the cooperation of Foxo3a with cyclic AMP- and Jun kinase-dependent Creb family members. Thus, Foxo3a not only is an effector of PKB but also integrates distinct signals to regulate gene expression in erythropoiesis.

Citing Articles

New insights into the mechanisms of red blood cell enucleation: From basics to clinical applications.

Zhuo Q, Zhang Z, Fang X EJHaem. 2024; 5(6):1301-1311.

PMID: 39691252 PMC: 11647694. DOI: 10.1002/jha2.1051.


Metformin as a Fetal Hemoglobin Inducer in Non-transfusion Dependent Thalassemia Patients.

ElTagui M, El-Ghamrawy M, AlDeeb S, Nassim M Indian J Hematol Blood Transfus. 2024; 40(1):68-73.

PMID: 38312174 PMC: 10831011. DOI: 10.1007/s12288-023-01662-1.


Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis.

Liang R, Lin M, Menon V, Qiu J, Menon A, Breda L Blood Adv. 2023; 7(22):6873-6885.

PMID: 37672319 PMC: 10685172. DOI: 10.1182/bloodadvances.2022007655.


Erythroid enucleation: a gateway into a "bloody" world.

Menon V, Ghaffari S Exp Hematol. 2021; 95:13-22.

PMID: 33440185 PMC: 8147720. DOI: 10.1016/j.exphem.2021.01.001.


Putative regulators for the continuum of erythroid differentiation revealed by single-cell transcriptome of human BM and UCB cells.

Huang P, Zhao Y, Zhong J, Zhang X, Liu Q, Qiu X Proc Natl Acad Sci U S A. 2020; 117(23):12868-12876.

PMID: 32457162 PMC: 7293633. DOI: 10.1073/pnas.1915085117.


References
1.
Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K, Motoyama N . FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem. 2002; 277(30):26729-32. DOI: 10.1074/jbc.C200256200. View

2.
Bates S, Rowan S, Vousden K . Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene. 1996; 13(5):1103-9. View

3.
Devary Y, Gottlieb R, Lau L, Karin M . Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol. 1991; 11(5):2804-11. PMC: 360059. DOI: 10.1128/mcb.11.5.2804-2811.1991. View

4.
Pilz R . Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells. J Biol Chem. 1993; 268(27):20252-8. View

5.
Bamforth S, Braganca J, Farthing C, Schneider J, Broadbent C, Michell A . Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat Genet. 2004; 36(11):1189-96. DOI: 10.1038/ng1446. View